Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

Most people on isotretinoin had chapped lips, but only a few stopped the medicine due to side effects.

Eating fewer calories, less sugar and refined carbs, and more low-glycemic and omega-3 rich foods can help manage PCOS symptoms.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Men with coeliac disease may have hormone imbalances that could affect sexual function, but these can improve with better gut health.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Minoxidil helps hair growth and reduces shedding in women.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Spironolactone plus finasteride reduces hirsutism more effectively.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Topical eye β-blockers may cause hair loss.

The document concludes that "Dictamnus" has a rich cultural history and potential as a herbal medicine, warranting more research into its effects and safety.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

A woman with acromegaloidism and normal growth hormone levels had a rare X-Tetrasomy, suggesting a need to study X-chromosome genes for their role in growth and facial development.

The document concludes that the hCG protocol may help in obesity treatment and could be scientifically justified, but more research is needed.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.